In order to ensure whether butyrate suppresses BC tumor growth by targeting TLR4-PDXK/SLC25A28 signalling pathway, T47D cells were transfected with the plasmid expressing TLR4 or empty plasmid, and simultaneously treated with 5.0 mM butyrate. This evidence concerns the gene PDXK and breast cancer.